Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biopharma In 2014: Early Access Gains Offset Taxation, Pricing Woes

Jan 21 2015

Related Content

Antibiotics: Officially Encouraged, Increasingly Precise, Still Risky

Oct 23 2014

Lessons From The First Biosimilar MAb Launch In Europe

Oct 20 2014

A Banner Year For Pharma: M&A Tops 2009 Merger Mania

Sep 18 2014

Adaptive Licensing: Industry On Board, With Caveats

Sep 30 2014

The UK’s Early Access Scheme: Breakthrough Or Mixed Blessing?

Aug 05 2014

Beyond "Breakthrough": FDA, Industry See Benefits For Drugs Outside Expedited Pathway

Nov 21 2014

After A Gargantuan Year For Pharma M&A, More To Come In 2015

Jan 12 2015

Related Companies

Pfizer Inc.

AstraZeneca PLC

Wyeth

Allergan plc

Warner Chilcott PLC

Forest Laboratories, Inc.

AbbVie Inc.

Takeda Pharmaceutical Co. Ltd.

Merck & Co., Inc.

Cubist Pharmaceuticals, Inc.

Hospira, Inc.

Schering-Plough

Roche Holding AG

InterMune, Inc.

Novartis AG

GSK plc

Idenix Pharmaceuticals, Inc.

Viatris Inc.

Abbott

Mallinckrodt plc

Cadence Pharmaceuticals, Inc.

Vital Therapies, Inc.

Alder Biopharmaceuticals, Inc.

Revance Therapeutics, Inc.

Ultragenyx Pharmaceutical Inc.

Eiger BioPharmaceuticals, Inc.

NephroGenex, Inc.

Adverum Biotechnologies, Inc.

Ampio Pharmaceuticals, Inc.

S1 Biopharma, Inc.

Bristol Myers Squibb Company

Bellicum Pharmaceuticals, Inc.

Kite Pharma, Inc.

Gilead Sciences, Inc.

Express Scripts Holding Company

CVS Caremark

CVS Health Corp.

Chiesi Farmaceutici S.p.A.

uniQure N.V.

Bayer AG

Additional Topics

Pricing Strategies Deals Reimbursement Business Strategies BioPharmaceutical

More from Deal-Making

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window